(-0.19%) 5 202.75 points
(-0.18%) 39 126 points
(-0.25%) 18 141 points
(0.80%) $79.62
(-0.32%) $2.18
(-0.32%) $2 314.90
(0.83%) $27.83
(0.61%) $990.60
(0.15%) $0.932
(0.33%) $10.93
(0.02%) $0.800
(1.10%) $92.75
-2.23% INR 1 166.20
Live Chart Being Loaded With Signals
Tatva Chintan Pharma Chem Limited manufactures and sells specialty chemicals in India. The company offers a portfolio of structure directing agents for zeolites synthesis; phase transfer catalysts; electrolyte salts for super capacitor batteries; and pharmaceutical APIs, agrochemical products, and other specialty chemicals in the form of intermediates, disinfectants, catalysts, and solvents...
Stats | |
---|---|
Today's Volume | 9 947.00 |
Average Volume | 28 354.00 |
Market Cap | 27.28B |
EPS | INR3.43 ( 2023-11-02 ) |
Last Dividend | INR2.00 ( 2023-09-08 ) |
Next Dividend | INR0 ( N/A ) |
P/E | 69.29 |
ATR14 | INR2.16 (0.18%) |
Volume Correlation
Tatva Chintan Pharma Chem Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Tatva Chintan Pharma Chem Correlation - Currency/Commodity
Tatva Chintan Pharma Chem Financials
Annual | 2023 |
Revenue: | INR3.94B |
Gross Profit: | INR1.39B (35.31 %) |
EPS: | INR13.26 |
FY | 2023 |
Revenue: | INR3.94B |
Gross Profit: | INR1.39B (35.31 %) |
EPS: | INR13.26 |
FY | 2022 |
Revenue: | INR4.24B |
Gross Profit: | INR1.98B (46.63 %) |
EPS: | INR20.52 |
FY | 2022 |
Revenue: | INR4.31B |
Gross Profit: | INR2.24B (51.85 %) |
EPS: | INR44.59 |
Financial Reports:
No articles found.
Tatva Chintan Pharma Chem Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR2.00 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR2.00 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | INR2.00 | 2022-09-08 |
Last Dividend | INR2.00 | 2023-09-08 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 2 | -- |
Total Paid Out | INR4.00 | -- |
Avg. Dividend % Per Year | 0.04% | -- |
Score | 2.49 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 2.79 | |
Div. Directional Score | 6.49 | -- |
Year | Amount | Yield |
---|---|---|
2022 | INR2.00 | 0.08% |
2023 | INR2.00 | 0.09% |
2024 | INR0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
SWARAJENG.NS | Dividend Knight | 2023-07-06 | Annually | 23 | 2.81% | |
NDRAUTO.NS | Dividend Junior | 2023-07-12 | Annually | 4 | 0.59% | |
ICICIGI.NS | Dividend Junior | 2023-06-12 | Annually | 8 | 0.36% | |
CENTENKA.NS | Dividend Junior | 2023-08-11 | Annually | 22 | 1.85% | |
RUPA.NS | Dividend Junior | 2023-08-01 | Annually | 13 | 0.60% | |
LINCOLN.NS | Dividend Junior | 2023-09-15 | Annually | 9 | 0.32% | |
GEECEE.NS | Dividend Junior | 2023-09-08 | Sporadic | 18 | 0.97% | |
ARIHANTCAP.NS | Dividend Junior | 2023-07-28 | Annually | 4 | 0.39% | |
TFCILTD.NS | Dividend Junior | 2023-08-11 | Annually | 23 | 1.38% | |
ORICONENT.NS | Dividend Junior | 2023-09-13 | Annually | 10 | 1.41% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0771 | 1.500 | 8.46 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0371 | 1.200 | 8.76 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0449 | 1.500 | -0.613 | -0.919 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 3.74 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 1.487 | 0.800 | 5.96 | 4.77 | [0.8 - 2.5] |
cashRatioTTM | 0.481 | 1.500 | 8.44 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0174 | -1.500 | 9.71 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 6.71 | 1.000 | 8.63 | 8.63 | [3 - 30] |
operatingCashFlowPerShareTTM | 19.26 | 2.00 | 3.58 | 7.16 | [0 - 30] |
freeCashFlowPerShareTTM | 19.26 | 2.00 | 0.371 | 0.742 | [0 - 20] |
debtEquityRatioTTM | 0.0194 | -1.500 | 9.92 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.505 | 1.000 | 4.92 | 4.92 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.111 | 1.000 | 9.77 | 9.77 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 3.07 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.481 | 0.800 | -0.129 | -0.103 | [0.5 - 2] |
Total Score | 10.20 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 88.34 | 1.000 | 1.177 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0449 | 2.50 | -0.394 | -0.919 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 19.26 | 2.00 | 3.58 | 0.742 | [0 - 30] |
dividendYielPercentageTTM | 0.170 | 1.500 | 5.76 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 19.26 | 2.00 | 3.58 | 7.16 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0 | 1.500 | -3.33 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.111 | 1.000 | 9.72 | 0 | [0.1 - 0.5] |
Total Score | 2.79 |
Tatva Chintan Pharma Chem
Tatva Chintan Pharma Chem Limited manufactures and sells specialty chemicals in India. The company offers a portfolio of structure directing agents for zeolites synthesis; phase transfer catalysts; electrolyte salts for super capacitor batteries; and pharmaceutical APIs, agrochemical products, and other specialty chemicals in the form of intermediates, disinfectants, catalysts, and solvents. It also provides quaternary compounds and quats, and bulk drugs, as well as trading of specialty chemicals. It serves various industries, including the automotive, petroleum, pharmaceutical, agro-chemicals, paints and coatings, dyes and pigments, personal care, and flavor and fragrances industries. The company also exports its products to approximately 25 countries. Tatva Chintan Pharma Chem Limited was incorporated in 1996 and is headquartered in Vadodara, India.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators